Inhibition of the accumulation of protease-resistant prion protein (PrP-res) is a prime strategy in the development of potential transmissible spongiform encephalopathy (TSE) therapeutics. Here we show that curcumin (diferoylmethane), a major component of the spice turmeric, potently inhibits PrP-res accumulation in scrapie agent-infected neuroblastoma cells (50% inhibitory concentration, ϳ10 nM) and partially inhibits the cell-free conversion of PrP to PrP-res. In vivo studies showed that dietary administration of curcumin had no significant effect on the onset of scrapie in hamsters. Nonetheless, other studies have shown that curcumin is nontoxic and can penetrate the brain, properties that give curcumin advantages over inhibitors previously identified as potential prophylactic and/or therapeutic anti-TSE compounds.
Transmissible spongiform encephalopathies (TSE) or prion diseases are untreatable, fatal neurodegenerative diseases that include bovine spongiform encephalopathy, chronic wasting disease, scrapie, and Creutzfeldt-Jakob disease. A central event in TSE diseases is the conversion of the normal, protease-sensitive isoform of prion protein (PrP-sen or PrP C ) to an abnormal, protease-resistant form, PrP-res or PrP Sc . Numerous compounds have been identified as inhibitors of PrPres formation in scrapie agent-infected murine neuroblastoma (ScNB) cells (1) (2) (3) 5) . The most potent of these inhibitors can also protect rodents against scrapie if they are administered near the time of infection (7, 8, 10, 11, 14) . Unfortunately, none of these compounds are known to be both safe and effective for use in humans and animals (8, 10, 11) . One therapeutic weakness of most of these compounds is likely an inability to penetrate the brain where most of the PrP-res accumulates and TSE pathogenesis occurs.
Curcumin, the major component of the spice turmeric and the yellow pigment in curry powder, has several properties that make it of interest as a possible anti-TSE drug. First, its structure resembles Congo red, the most potent of the small-molecule PrP-res inhibitors that have been assayed in ScNB cells ( Fig. 1 ) in that both are potentially planar compounds that have two aromatic rings or ring systems with conjugated linkers. Structure-activity studies have provided evidence that the potential for coplanarity of the rings and linker is important for the inhibitory potency of Congo red (6) . Second, unlike Congo red, curcumin is uncharged and is thought to have at least limited bioavailability to the brain after consumption. Indeed, recent studies with a rat model of Alzheimer's disease reported that dietary curcumin reduces ␤-peptide deposition in the brain as well as associated neuropathology and cognitive deficits (9, 12) . Third, curcumin has antioxidant activity, a factor that may be important given that oxidative damage is a feature in TSE neuropathogenesis (13) . Fourth, humans consume curcumin in large amounts with no apparent toxicity. Toxicology studies have indicated that rodents can tolerate for a long period up to 5% of their diet being turmeric oleoresin (ϳ80% curcumin) without their life spans being shortened (http://ntp -server.niehs.nih.gov/htdocs/LT-studies/tr427.html). These considerations prompted us to test whether curcumin could inhibit the formation and accumulation of PrP-res.
Curcumin was added to the culture medium of ScNB cells seeded at a density of 1/10 confluence and grown to near confluence for 3 to 4 days. Approximately 90% of the ScNB cells used to seed these cultures were infected, as was indicated by the fact 9 out of 10 single-cell subclones from concurrent passes of this ScNB cell line were highly positive for PrP-res (data not shown). The accumulation of PrP-res during the growth of the ScNB cultures was assayed by detergent extraction, proteinase K (PK) treatment, and immunoblotting by previously described methods (5) . A curcumin concentrationdependent reduction of PrP-res accumulation was observed with a concentration giving half maximal inhibition of ϳ10 nM ( Fig. 2A and B ). This 50% inhibitory concentration rivals that of Congo red (ϳ10 nM) (2, 3) and is 2,500-fold lower than the concentration of curcumin (25 M) that began to show evidence of cytotoxicity in the ScNB cells (not shown). The curcumin-induced reduction in PrP-res was long-lasting because the PrP-res levels in cultures treated with 1 M curcumin for 4 days (one pass) remained low after four subsequent passes in the absence of curcumin (Fig. 2C) . The observed effects of curcumin were not due to artifactual interference with the detection of PrP-res or an enhancement of the protease sensitivity of PrP-res after lysis of the cells, because addition of 1 M curcumin to the otherwise untreated control cell lysates prior to PK digestion did not affect the amount of PrP-res detected (Fig. 2D) . Furthermore, incubation of purified hamster 263K strain PrP-res (0.13 M) with curcumin concentrations of up to 5 mM in 50 mM Tris-HCl-150 mM NaCl, pH 8, for 16 h at room temperature did not enhance its sensitivity to PK or reduce its detection by immunoblotting (data not shown). The inhibition of PrP-res accumulation in the ScNB cells by curcumin was not due to a reduction of protein synthesis generally or PrP-sen biosynthesis specifically because there was no reduction in the metabolic labeling of cellular proteins (Fig. 3A) or PrP-sen (Fig. 3B ) after either 1-h or 4-day treatments with 1 M curcumin, a concentration that fully inhibited PrP-res accumulation in the intact cells. Taken together, these results provide evidence that curcumin inhibits PrP-res accumulation potently, irreversibly, and selectively in live ScNB cells.
To test the direct effects of curcumin on the conversion of PrP-sen to PrP-res, we used cell-free conversion reaction mixtures in which purified hamster PrP-res (263K strain) induces the conversion of hamster 35 S-PrP-sen to 35 S-PrP-res. Partial mean inhibition of up to 41% (at 10 M curcumin) was observed under previously described conditions with guanidine hydrochloride and detergents (6) (Fig. 4) .
Tests of the prophylactic anti-TSE effects of curcumin in Further experiments are under way to determine whether curcumin is more effective against lower oral, intraperitoneal, and intracerebral doses of scrapie agents of different strains and in different host species. Furthermore, it is possible that other routes of administration of curcumin may be more effective than mixing it with feed. Although curcumin has been demonstrated to exert some beneficial effects in the brains of rats with Alzheimer's disease (9, 12) , it remains to be determined how well it accumulates in the brain after oral administration to other species (e.g., hamsters and mice). Disease state might also impact curcumin's blood-brain-barrier permeability in a species-dependent manner.
In conclusion, curcumin is among the smallest and most potent inhibitors of PrP-res formation to be identified in vitro. Our initial tests have not indicated that dietary curcumin is effective against high intracerebral doses of scrapie in vivo. However, continued study of curcumin as a potential lead compound for TSE prophylaxis and therapeutics seems warranted because of the major advantages that it has over other known PrP-res inhibitors, namely, lack of toxicity and carcino- 35 S-PrP-sen lacking a glycophosphatidylinositol anchor (20,000 cpm) was immunoprecipitated from fibroblast cells and incubated with PrP-res that had been isolated from the brains of 263K scrapie-infected hamsters and pretreated with 2 M guanidine HCl (6) . The final conditions of the conversion incubation were 300 nM PrP-res, ϳ5 nM PrP-sen, 0.5 M guanidine hydrochloride, 50 mM sodium citrate [pH 6.5], 1 mM cetyl pyridinium chloride, 0.6% N-lauroyl sarkosine, and 37°C. The formation of 35 SPrP-res (marked by the right bracket) was detected by treating 90% of the reaction equivalents with PK (10 g/ml) for 1 h at 37°C, followed by the inactivation of the PK with Pefabloc (Boehringer Mannheim), methanol precipitation, and SDS-PAGE analysis as described previously (6) . The remaining 10% of the reaction mixture was analyzed without PK digestion to show the input on September 7, 2017 by guest http://jvi.asm.org/ genicity, apparent oral bioavailability to the brain (9, 12) , and antioxidant activity.
